Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Ethics Forum: Personal Ethics Questions Surrounding RheumPAC Donations

Matthew L. Mundwiler, MD, & Robert H. Shmerling, MD  |  Issue: October 2015  |  October 14, 2015

Ethically, it’s easy to see the conflict. The system places a premium on money generated in a way that is often independent of the goal of improving the lives of constituents, including our patients. Unfortunately, if we defer participation in the political process until it’s overhauled to a more ethically comfortable state, our profession and our patients may suffer.

To encourage the ACR membership to participate politically, RheumPAC provides a resource to use funds from member donations to access fundraising events. A committee of volunteer rheumatologists determines who to support based on the legislator’s record of supporting rheumatology. Any ACR member can recommend an elected official for consideration.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Success Stories
The ACR, with the aid of relationships built through RheumPAC, was recently able to influence the repeal of the Sustainable Growth Rate (SGR) formula for physician reimbursement under Medicare, delay ICD-10 implementation and have the implementation of ICD-10 occur under more favorable conditions.1

Current Government Affairs Committee Chair William Harvey, MD, was given the opportunity to testify on behalf of legislation we drafted, the Patients’ Access to Treatment Act (HR 1600).2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Across Party Lines
Although success has been achieved, the proportion of ACR members contributing to RheumPAC is relatively low. At a 3.8% member participation rate and $225,000 contributed over the two-year 2014 election cycle, our participation is lower than many other specialties, including Orthopedic Surgery (21% participation, $2,181,500 contributed) and Family Medicine (6% participation, $757,000 contributed).1,3,4,5,6

While serving on the GAC, I found it hard to understand why the percentage of rheumatologists making at least a nominal donation remained small. When I moved from the GAC and shared this concern with the members of the Committee on Ethics and Conflict of Interest, reasons for low participation became clear. I realized the individual decision to donate to politicians, even indirectly through RheumPAC, is ethically complicated. Even if a politician supports rheumatologists’ concerns without reservation, the same politician could support a position that is in direct opposition to what an individual ACR member finds important in areas outside of rheumatology.

For RheumPAC, the primary determining factor is a candidate’s views and actions pertaining to rheumatology. Because major differences of opinion on high-profile issues often exist along party lines, RheumPAC has given its funds as equally as possible to Democrats and Republicans.7

The AMA’s code of ethics states that “physicians have a responsibility to work for the reform of, and to press for the proper administration of, laws that are related to health care. Physicians should keep themselves well informed as to current political questions regarding needed and proposed changes to laws concerning such issues as access to health care, quality of health care services, scope of medical research, and promotion of public health.”8

Page: 1 2 3 | Single Page
Share: 

Filed under:EthicsLegislation & AdvocacyProfessional Topics Tagged with:AdvocacydonationsEthicsLegislationPoliticsrheumatologistsrheumatologyRheumPAC

Related Articles

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    November, a Busy Month for RheumPAC

    October 21, 2022

    In November, RheumPAC will be leading its annual matching campaign and hosting two events at ACR Convergence 2022. Thanks to matching donors, every contribution in November will be amplified.

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences